CLU and familial pancreatic carcinoma: In the present study, we showed a significant correlation between clusterin expression and gmcitabine IC50 in the pancreatic cancer cell lines, we tested the hypothesis that clusterin expression may confer gmcitabine resistance in pancreatic cancer cells.